XML 109 R72.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements - Financial Instruments at Fair Value (Details) - USD ($)
$ in Millions
Dec. 31, 2017
Dec. 31, 2016
Oct. 02, 2016
Sep. 30, 2016
Apr. 03, 2016
Mar. 01, 2016
Dec. 31, 2015
Assets:              
Royalty Pharma contingent milestone payments           $ 30.0  
Financial assets $ 0.0 $ 2,350.0         $ 5,310.0
Indefinite-lived intangible assets       $ 674.4      
Liabilities:              
Indefinite-lived intangible assets, gross 90.3 114.5         1,916.3
Definite lived assets, gross 4,661.7 4,417.2         3,705.3
Recurring | Level 1              
Assets:              
Investment securities 17.0 38.2         14.9
Recurring | Level 2              
Assets:              
Foreign currency forward contracts 6.3 3.8         4.8
Funds associated with Israeli severance liability 16.3 15.9         17.2
Total assets 22.6 19.7         22.0
Liabilities:              
Interest rate swap agreements 0.0 0.0         0.3
Foreign currency forward contracts 3.8 5.0         3.9
Total liabilities 3.8 5.0         4.2
Recurring | Level 3              
Assets:              
Royalty Pharma contingent milestone payments 134.5 0.0         0.0
Financial assets 0.0 2,350.0         5,310.0
Total assets 134.5 2,350.0         5,310.0
Liabilities:              
Contingent consideration 22.0 69.9         17.9
Nonrecurring              
Assets:              
Indefinite-lived intangible assets         $ 364.5    
Liabilities:              
Intangible assets, gross             1,200.0
Definite lived assets, gross 31.2 2,300.0          
Nonrecurring | Level 3              
Assets:              
Goodwill [1] 0.0 1,148.4         0.0
Indefinite-lived intangible assets 0.0 [2] 0.3 [2] $ 674.2       1,031.8 [2]
Definite-lived intangible assets [3] 11.5 758.0         0.0
Assets held for sale, net 0.0 18.2         37.5
Total assets $ 11.5 1,924.9         $ 1,069.3
Liabilities:              
Goodwill, gross   2,200.0          
Indefinite-lived intangible assets, gross   $ 0.7          
[1] As of December 31, 2016, goodwill with a carrying amount of $2.2 billion was written down to its implied fair value of $1.1 billion.
[2] As of December 31, 2016, indefinite-lived intangible assets with a carrying amount of $0.7 million were written down to a fair value of $0.3 million. As of December 31, 2015, indefinite-lived intangible assets with a carrying amount of $1.2 billion were written down to a fair value of $1.0 billion.
[3] As of December 31, 2017, definite-lived intangible assets with a carrying amount of $31.2 million were written down to a fair value of $11.5 million. As of December 31, 2016, definite-lived intangible assets with a carrying amount of $2.3 billion were written down to a fair value of $758.0 million. Included in this balance are indefinite-lived intangible assets with a fair value of $364.5 million and $674.2 million that were reclassified to definite-lived assets at April 3, 2016 and October 2, 2016, respectively.